| Literature DB >> 26481152 |
Lara Fakhouri1, Tamam El-Elimat1, Dow P Hurst1, Patricia H Reggio1, Cedric J Pearce2, Nicholas H Oberlies1, Mitchell P Croatt1.
Abstract
(5Z)-7-Oxozeanol and related analogues were isolated and screened to explore their activity as TAK1 inhibitors. Seven analogues were synthesized and more than a score of natural products isolated that examined the role that different areas of the molecule contribute to TAK1 inhibition. A novel nonaromatic difluoro-derivative was synthesized that had similar potency compared to the lead. This is the first example of a nonaromatic compound in this class to have TAK1 inhibition. Covalent docking for the isolated and synthesized analogues was carried out and found a strong correlation between the observed activities and the calculated binding.Entities:
Keywords: (5Z)-7-Oxozeaenol; Covalent docking; Resorcylic acid lactone; Selectfluor®; TAK1
Mesh:
Substances:
Year: 2015 PMID: 26481152 PMCID: PMC4661079 DOI: 10.1016/j.bmc.2015.09.037
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.461